Engineered plasma cells show long-lasting antileukemic activity in mice

byCell PressAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainResearchers show for the first time that engineered human plasma B cells can be used to treat a disease—specificall

Updated on: July 05,2024

Engineered plasma cells show long-lasting antileukemic activity in mice

byCell PressAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainResearchers show for the first time that engineered human plasma B cells can be used to treat a disease—specificall

Updated on:July 05,2024

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Updated on: April 01,2024

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Updated on:April 01,2024

Quest for better pancreatic cancer tests gains insights from survivor's data

byFlinders UniversityCA19-9 and PSA serum levels. (A) CA19-9 and PSA levels from 15th May 2017 to 27th January 2023. (B) Simple linear regression of CA19-9 and PSA at all-time points. Credit:&nb

Updated on: July 09,2024

Quest for better pancreatic cancer tests gains insights from survivor's data

byFlinders UniversityCA19-9 and PSA serum levels. (A) CA19-9 and PSA levels from 15th May 2017 to 27th January 2023. (B) Simple linear regression of CA19-9 and PSA at all-time points. Credit:&nb

Updated on:July 09,2024

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese

Updated on: May 25,2024

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese

Updated on:May 25,2024

Miami's Little Haiti joins global effort to end cervical cancer

by Verónica ZaragoviaCredit: Unsplash/CC0 Public DomainMore than 300,000 women around the world die from cervical cancer each year. In the U.S., women of Haitian descent are diagnosed with it at highe

Updated on: December 28,2023

Miami's Little Haiti joins global effort to end cervical cancer

by Verónica ZaragoviaCredit: Unsplash/CC0 Public DomainMore than 300,000 women around the world die from cervical cancer each year. In the U.S., women of Haitian descent are diagnosed with it at highe

Updated on:December 28,2023

A step forward in the struggle against neuroblastoma, a type of childhood cancer

by University of SevilleCredit: CC0 Public DomainA group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla—IBiS) has publish

Updated on: March 09,2024

A step forward in the struggle against neuroblastoma, a type of childhood cancer

by University of SevilleCredit: CC0 Public DomainA group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla—IBiS) has publish

Updated on:March 09,2024

The molecules behind metastasis

by Greta Friar,Whitehead Institute for Biomedical ResearchBreast cancer stem cells (red) that have reached the lung begin to divide into clusters that could become metastatic tumors. Credit: Art

Updated on: January 21,2024

The molecules behind metastasis

by Greta Friar,Whitehead Institute for Biomedical ResearchBreast cancer stem cells (red) that have reached the lung begin to divide into clusters that could become metastatic tumors. Credit: Art

Updated on:January 21,2024

Researchers find protein that mediates formation of HER2-driven breast cancer

by Katie Pence,University of Cincinnati Academic Health CenterCredit: CC0 Public DomainResearchers at the University of Cincinnati College of Medicine have identified for the first time that the

Updated on: June 22,2024

Researchers find protein that mediates formation of HER2-driven breast cancer

by Katie Pence,University of Cincinnati Academic Health CenterCredit: CC0 Public DomainResearchers at the University of Cincinnati College of Medicine have identified for the first time that the

Updated on:June 22,2024

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and

Updated on: July 17,2024

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions

by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and

Updated on:July 17,2024

Global study predicts more than 50 percent rise in chemotherapy demand by 2040

byLancetCredit: CC0 Public DomainTo deliver optimal treatment by 2040, a significant expansion of the chemotherapy workforce is needed.Between 2018 and 2040, the number of patients requiri

Updated on: May 23,2024

Global study predicts more than 50 percent rise in chemotherapy demand by 2040

byLancetCredit: CC0 Public DomainTo deliver optimal treatment by 2040, a significant expansion of the chemotherapy workforce is needed.Between 2018 and 2040, the number of patients requiri

Updated on:May 23,2024

Researchers identify the mutations that drive resistance to PI3K inhibitors in breast cancer, find they can be overcome

by Mass General BrighamSecondary mutations in the PI3K/AKT pathway emerge during treatment with inavolisib and lead to acquired resistance. A-B, Droplet digital PCR analysis of serial ctDNA sampl

Updated on: June 24,2024

Researchers identify the mutations that drive resistance to PI3K inhibitors in breast cancer, find they can be overcome

by Mass General BrighamSecondary mutations in the PI3K/AKT pathway emerge during treatment with inavolisib and lead to acquired resistance. A-B, Droplet digital PCR analysis of serial ctDNA sampl

Updated on:June 24,2024

Enlarged genotype-phenotype correlation for a three-base pair deletion in neurofibromatosis type 1

by Jeff Hansen,University of Alabama at BirminghamLudwine Messiaen, Ph.D., left, and Magdalena Koczkowska, Ph.D. Credit: University of Alabama at BirminghamInternational collaborative research l

Updated on: March 14,2024

Enlarged genotype-phenotype correlation for a three-base pair deletion in neurofibromatosis type 1

by Jeff Hansen,University of Alabama at BirminghamLudwine Messiaen, Ph.D., left, and Magdalena Koczkowska, Ph.D. Credit: University of Alabama at BirminghamInternational collaborative research l

Updated on:March 14,2024